China Parenteral Nutrition Market Size & Outlook
China parenteral nutrition market, 2018-2030 (US$M)
Related Markets
China parenteral nutrition market highlights
- The China parenteral nutrition market generated a revenue of USD 340.7 million in 2023 and is expected to reach USD 555.3 million by 2030.
- The China market is expected to grow at a CAGR of 7.2% from 2024 to 2030.
- In terms of segment, oral was the largest revenue generating product in 2023.
- Oral is the most lucrative product segment registering the fastest growth during the forecast period.
Parenteral nutrition market data book summary
| Market revenue in 2023 | USD 340.7 million |
| Market revenue in 2030 | USD 555.3 million |
| Growth rate | 7.2% (CAGR from 2023 to 2030) |
| Largest segment | Oral |
| Fastest growing segment | Oral |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Enteral |
| Key market players worldwide | Baxter International Inc, Allergan, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical, Grifols SA Ordinary Shares - Class A, B. Braun, CSL Ltd, Fresenius SE & Co KGaA, Pfizer Inc, Sichuan Kelun Pharmaceutical |
Other key industry trends
- In terms of revenue, China accounted for 4.8% of the global parenteral nutrition market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China parenteral nutrition market is projected to lead the regional market in terms of revenue in 2030.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 218.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Parenteral Nutrition Market Scope
Parenteral Nutrition Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China parenteral nutrition market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to parenteral nutrition market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 86.65% in 2023. Horizon Databook has segmented the China parenteral nutrition market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
China is a rapidly emerging market owing to the presence of a large patient pool, a rising elderly population, which is boosting the demand for high-quality medical facilities, and increasing prevalence of chronic diseases.
The rate of undernutrition is also high in this country. According to diabetes country profiles released by WHO in 2016, cardiovascular diseases and cancer accounted for the majority of the deaths in the country.
Reasons to subscribe to China parenteral nutrition market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China parenteral nutrition market databook
-
Our clientele includes a mix of parenteral nutrition market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China parenteral nutrition market , including forecasts for subscribers. This country databook contains high-level insights into China parenteral nutrition market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China parenteral nutrition market size, by stage, 2018-2030 (US$M)
China Parenteral Nutrition Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
